Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (2): 99-104.doi: 10.6040/j.issn.1673-3770.0.2018.337

Previous Articles     Next Articles

Phacoemulsification combined with intravitreal ranibizumab or triamcinolone acetonide injection for the treatment of cataract accompanied by diabetic macular edema

LIU Jianbo1, ZHANG Huan2   

  1. Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong, China
  • Published:2019-03-28

PDF (PC)

317

Abstract: Objective To investigate the efficacy and safety of phacoemulsification combined with intravitreal ranibizumab or triamcinolone acetonide injection for treating patients with cataract accompanied by diabetic macular edema(DME). Methods In this case-control study, 66 patients(78 eyes)with cataract complicated by DME were randomly divided into three groups. The control group was treated with phacoemulsification and intraocular lens implantation. The IVR group was treated with cataract surgery and intravitreal ranibizumab injection. The IVTA group was treated with cataract surgery and intravitreal triamcinolone acetonide injection. The differences in best corrected visual acuity(BCVA), macular center retinal thickness(CRT), and intraocular pressure were compared among the three groups preoperatively and 1 week, 1 month, 3 months, and 6 months postoperatively. Results There were no significant differences in sex, age, duration of DM, preoperative BCVA(LogMAR), CRT, and intraocular pressure among the three groups(P>0.05). The overall trend(time)of BCVA(LogMAR)and CRT changes with time in the three groups before and after operation was significant(P<0.05). The trend(time*group)of BCVA(LogMAR)and CRT changes over time among the three groups was significant. The comprehensive differences(group)in BCVA(LogMAR)and CRT among the three groups were also significant regardless of time(P<0.05). Comparison of BCVA(LogMAR)and CRT among the three groups revealed a significant difference between the IVR group and control group, and between the IVTA group and control group(P<0.05). In addition, there was no significant difference between the IVR and IVTA groups in BCVA(LogMAR)and CRT(P>0.05). The overall trend(time)of intraocular pressure changes with time in the three groups was significant(P<0.001). The trend(time*group)of intraocular pressure changes over time among the three groups was significant(P<0.001). In 1 week and 1 month after operation, the intraocular pressure of the IVTA group increased, and there was significant difference between the IVTA group and the control group, and between the IVTA group and the IVR group(P<0.05). The comprehensive difference(group)in intraocular pressure among the three groups was not significant regardless of time(P=0.249). Conclusion Phacoemulsification combined with intravitreal ranibizumab or triamcinolone acetonide injection can improve BCVA and reduce macular edema in patients with cataract accompanied by DME. In addition, ranibizumab does not cause an increase in intraocular pressure and is safer and more reliable than triamcinolone acetonide.

Key words: Cataract, Diabetic retinopathy/complications, Macular edema, Antibodies, monoclonal, humanized, Glucocorticoids

CLC Number: 

  • R774.1
[1] 陈红娟,陈建英,李琳. 两种术式治疗糖尿病视网膜病变合并白内障疗效比较[J].山东医药,2010,50(5):69-70. doi:10.3969/j.issn.1002-266X.2010.05.033. CHEN Hongjuan, CHEN Jianying, LI Lin. Comparison of two methods in the treatment of diabetic retinopathy with cataract[J]. Shandong Med J, 2010, 50(5):69-70. doi:10.3969/j.issn.1002-266X.2010.05.033.
[2] 张岩,马军艳,王翠,等. 玻璃体腔注射曲安奈德对糖尿病性视网膜病变患者超声乳化白内障吸除术后黄斑厚度的影响[J]. 中华眼科医学杂志,2015,5(6): 24-29.doi:10.3877/cma.j.issn.2095-2007.2015.06.004. ZHANG Yan, MA Junyan, WANG Cui, et al. Effect of intravitreal triamcinolone acetonide injection on macular thickness in diabetic retinopathy patients having phacoemulsification[J]. Chin J Ophthalmol Med, 2015, 5(6):24-29. doi:10.3877/cma.j.issn.2095-2007.2015.06.004.
[3] 许迅,郑颖. 重视对糖尿病黄斑水肿的治疗[J].中华眼底病杂志,2016,32(2):119-121. doi:10.3760/cma.j.issn.1005-1015.2016.02.002. XU Xun, ZHENG Ying. Focusing on the treatment of diabetic macular edema[J]. Chin J Ocul Fundus Dis, 2016, 32(2):119-121. doi:10.3760/cma.j.issn.1005-1015.2016.02.002.
[4] 林为华,卢敏,唐浩英,等. 雷珠单抗在糖尿病性白内障治疗中的临床应用[J].国际眼科杂志,2015,15(5):880-882. doi:10.3980/j.issn.1672-5123.2015.5.37 LIN Weihua, LU Min, TANG Haoying, et al. Clinical application of Ranibizumab in the therapy of diabetic cataract[J]. Int J Ophthalmol, 2015, 15(5):880-882. doi:10.3980/j.issn.1672-5123.2015.5.37
[5] 程明智,王翠,陈明. 超声乳化联合玻璃体内注射雷珠单抗治疗糖尿病性白内障的临床观察[J].眼科新进展,2016,36(8):754-756. doi:10.13389/j.cnki.rao.2016.0201. CHENG Mingzhi, WANG Cui, CHEN Ming. Phacoemulsification combined with intravitreal injection of lucentis for diabetic cataract[J]. Rec Adv Ophthalmol, 2014, 30(2):141-144. doi:10.13389/j.cnki.rao.2016.0201.
[6] 戴昳宁,郑霖,戴荣平,等. 白内障超声乳化手术中联合玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿合并重度白内障的疗效观察[J].中华眼底病杂志,2014,30(2):141-144. doi:10.3760/cma.j.issn.1005-1015.2014.02.006. DAI Yining, ZHENG Lin, DAI Rongping, et al. Phacoemulsification with intravitreal triamcinolone injection to treat diabetic macular edema with severe cataract[J]. Chin J Ocul Fundus Dis, 2014, 30(2):141-144. doi:10.3760/cma.j.issn.1005-1015.2014.02.006.
[7] Chae JB, Joe SG, Yang SJ, et al. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy[J]. Retina(Philadelphia, Pa), 2014, 34(1): 149-156. doi:10.1097/IAE.0b013e3182979b9e.
[8] 邵娜,张晗. 糖尿病患者行白内障超声乳化术后视力及眼底的变化[J].山东大学耳鼻喉眼学报,2016,30(1):83-87. doi:10.6040/j.issn.1673-3770.0.2015.341. SHAO Na, ZHANG Han. Variation of visual acuity and fundus in type 2 diabetic patients after phacoemulsification surgery[J]. J Otolaryngol Ophthalmol Shandong Univ, 2016, 30(1):83-87. doi:10.6040/j.issn.1673-3770.0.2015.341.
[9] 李弘. 超声乳化白内障术后糖尿病性视网膜和黄斑病变研究进展[J].中国实用眼科杂志,2014,32(5):538-542. doi:10.3760/cma.j.issn.1006-4443.2014.05.003. LI Hong. Research progress of diabetic retinopathy and macular degeneration after phacoemulsification[J].Chin J Pract Ophthalmol, 2014, 32(5):538-542. doi:10.3760/cma.j.issn.1006-4443.2014.05.003.
[10] 杨柳,张婧. 糖尿病性黄斑水肿治疗方法的选择[J].中华眼科杂志,2017,53(10):724-728. doi:10.3760/cma.j.issn.0412-4081.2017.10.002. YANG Liu, ZHANG Jing. Choice of treatment for diabetic macular edema[J]. Chin J Ophthalmol, 2017, 53(10):724-728. doi:10.3760/cma.j.issn.0412-4081.2017.10.002.
[11] 韩月圣,魏文斌. Ranibizumab玻璃体腔注射后糖尿病黄斑水肿患者中心视网膜厚度相对变化与视力预后的关系[J]. 中华实验眼科杂志, 2016,34(1):78-84. doi:10.3760/cma.j.issn.2095-0160.2016.01.017. HAN Yuesheng, WEI Wenbin. The relationship between central retinal thickness relative change and visual prognosis in diabetic macular edema patients following intravitreal injection of ranibizumab[J]. Chin J Exp Ophthalmol, 2016, 34(1):78-84. doi:10.3760/cma.j.issn.2095-0160.2016.01.017.
[12] 杨波, 宋艳. 超声乳化联合曲安奈德玻璃体腔内注射治疗白内障合并糖尿病黄斑水肿[J]. 国际眼科杂志, 2015, 15(9):1532-1535. doi:10.3980/j.issn.1672-5123.2015.9.10 YANG Bo, SONG Yan. Therapeutic effects of phacoemulsification combined with intravitreal injection of triamcinolone in treating cataract with diabetic macular edema[J]. Int J Ophthalmol, 2015, 15(9):1532-1535. doi:10.3980/j.issn.1672-5123.2015.9.10
[13] 唐瑞雪. 玻璃体腔内注射曲安奈德与贝伐单抗治疗白内障术后黄斑水肿的疗效[J]. 国际眼科杂志,2016,16(1):135-137. doi:10.3980/j.issn.1672-5123.2016.1.38. TANG Ruixue. Effect of intravitreal injection of triamcinolone acetonide and bevacizumab for macular edema after cataract surgeries[J]. Int J Ophthalmol, 2016, 16(1):135-137. doi:10.3980/j.issn.1672-5123.2016.1.38.
[14] 吕勇,范琼艳,杨琳,等.老年白内障手术联合玻璃体腔注射雷珠单抗对糖尿病性黄斑水肿影响[J]. 中国实用眼科杂志,2014,32(5):560-563. doi:10.3760/cma.j.issn.1006-4443.2014.05.009. LVE Yong, FAN Qiongyan, YANG Lin, et al. Effect of combined senile diabetic cataract surgery and intravitreal lucentis injection on diabetic macular edema[J]. Chin J Pract Ophthalmol, 2014, 32(5):560-563. doi:10.3760/cma.j.issn.1006-4443.2014.05.009.
[1] WANG Xinmeng, JI Junya, YU Haonan, FU Hongchen, WANG Xiang, ZHENG Zekun, LI Yan, ZHONG Yingying. Analysis of refractive prediction accuracy after phacoemulsification combined with goniosynechialysis in acute Angle closure glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 74-79.
[2] LIU Zhen, ZHOU Weiwei, LIU Hanjing, ZHANG Yi, ZHU Yuguang, ZHU Yan. Influence of Alpha angle of intraocular lens on visual quality after the implantation of extended depth-of-field intraocular lens [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 47-53.
[3] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[4] SUN Qingzhu, SHEN Jian, CHEN Xing, WU Yanbing, ZENG Lun. The role of metabolic indicators in predicting ranibizumab efficacy in diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 74-81.
[5] ZHU Yunlong, WANG Ping, GAO Meng. A case of posterior scleritis initially misdiagnosed as central serous chorioretinopathy and retinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 99-105.
[6] HUANG Qi, DENG Xuwen, WANG Peipei, CHEN Yequn, GU Xuejun. Research on evaluating the cataract surgery level of ophthalmologists using eyeSi surgical simulator [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 83-88.
[7] DING Shuliang, WANG Chaofan, LIU Jianliang. A case of intraocular fluid detection to guide precise treatment of acute retinal necrosis and review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 114-117.
[8] WANG Sheng, HUANG Xudong. Recent advancements in the research on ferroptosis and age-related cataracts [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 161-168.
[9] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[10] SUN Hongxiang, CAO Juan. Status of mental fragility in elderly cataract patients and its correlation with hope level and alexithymia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 89-95.
[11] WANG Zhenxiao, SHI Guanggang, HE Mingqiang, SHI Lei. Treatment options and management strategies for patients with acute laryngotracheobronchitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 136-144.
[12] SHEN Jiaqi, LI Xiaosa, BI Yanlong, ZHANG Jingfa. The application of artificial intelligence in screening, diagnosis and prognosis of diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 153-159.
[13] MA Jiling, WANG Xiaoming, LI Yan, MU Yanxiao, JIN Lin, KONG Hui, YANG Naifu, DANG Guangfu. Evaluation of three different aspheric intraocular lens tilts and decentrations in capsular bags after cataract surgery based on CASIA2 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 76-85.
[14] BAO Ying, LIU Zhigao, JANG Pengfei, CUI Wenxuan, ZHENG Xiaoxia, YANG Mengyao, SI Mingwei, WANG Yu, WANG Hong. Clinical observation of compacept in the treatment of diabetes mellitus with CRVO-ME high reflex point [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 55-60.
[15] CHANG Weiwei, JIAO Wanzhen, CUI Yanyan, ZHAO Jie, LIU Zhaoqiang, ZHAO Bojun. Research progress of diabetic macular ischaemia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 130-136.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd